8/4/2022Sanofi Enters Strategic and €300M Investment Pact with Innovent for ...

8/3/2022Review of Chinese New Drug Clinical Trial Applications in H1/2022

8/2/2022CDE Solicits Comments on Draft "Common Pharmacy Issues and Related Tec...

8/2/2022NHC: Chinese Population to Start Declining by 2025

8/2/2022Nippon Express (China) Opens New Healthcare Branch in Shanghai

8/2/2022China Slaps MAH System on Vaccine Manufacturing to Limit Newcomers (Ph...

8/1/2022Prevalence of Stroke in China, 2013–2019: A Population-based Study

8/1/2022CDE Issues the Q&As on Non-Clinical and Clinical Evaluation Criteria f...

8/1/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...

7/29/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines ICH ...

7/29/2022NHC and SATCM Issues Notice to Further Strengthen Drug Safety Manageme...

7/29/2022Recent Official and Executive Moves

7/29/2022Drug R&D and Product Registration News Digest July 2022 (4)

7/29/2022Financial-related Company News in Brief (July 2022)

7/29/2022Drug R&D and Approvals in China – June Update on YouTube (PharmCube)

7/29/2022Pricing and Market Access in China: How Medtechs Can Succeed

7/28/2022June In-Licensing Deals in China Biotech Drop to A New Low (PharmaDJ)

7/28/2022Cosmo and 3SBio Enter License Agreement for Winlevi in Greater China

7/28/2022Elevation Oncology and CSPC Pharma Enter Licensing Deal for Latter's A...

7/27/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (61...

7/26/2022Rona Therapeutics Licenses Sanofi's Broad siRNA Therapeutic Portfolio ...

7/26/2022NHSA and MOF Issues Notice to Further Implement BMI Inter-provincial M...

7/26/2022CDE Solicits Comments on the Draft Guidelines for Blinding Drug Clinic...

7/26/2022China Clears Domestically-made HIV Pill for COVID-19

7/26/2022MSD and Kelun Enter Oncology Research Collaboration and License Agre...

7/26/2022Nicholas Hall Reports Softening Chinese CHC and Analgesics Market Grow...

7/26/2022Snapshot: Top Ten Chinese New Drug Projects by Accumulative R&D Invest...

7/26/2022Review of Chinese Hospital Drug Market in Q1/2022

7/26/2022Mybio Capital's China Pharma BD Transactions Report H1/2022

7/26/2022Biotech fundraising in China Warms Up A Little in June (PharmaDJ)

Page:76/719 Total number of articles:21546: [First][<<] [74] [75] [76] [77] [78] [>>] [End]